Sector News

GSK appoints Debjit Rudra as South-east Asia GM

September 3, 2015
Life sciences

GlaxoSmithKline (GSK) Consumer Healthcare has appointed Debjit Rudra as General Manager of its south-east Asia operations.

Based in Singapore, Mr Debjit will oversee GSK’s consumer healthcare business across South East Asia, reporting directly to Zubair Ahmed who heads the Asia Middle East Africa region.

He was previously Asia Vice President of Unilever’s Household Care division. He held key positions in sales, marketing and senior regional leadership roles during his 22-year tenure at the company.

Most recently, Mr Debjit assumed the role of Asia Vice President of Unilever’s Household Care division, playing a central role in the development and implementation of Unilever’s strategic roadmap for the category across Asia and ANZ.

Source: Asia Online

comments closed

Related News

February 4, 2023

MedTrace receives U.S. patent for diagnosing the human heart

Life sciences

The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the human heart via 15O-water PET. The patented method is the foundation of the company’s software aQuant, currently under development. Hendrik “Hans” Harms, PhD and Senior Scientist at MedTrace, and Jens Soerensen, Professor and Clinical Advisor to MedTrace, are the originators of the method.

February 4, 2023

Roche taps insider Teresa Graham for top pharma job as setbacks prompt M&A questions

Life sciences

Teresa Graham, currently head of global product strategy for Roche pharma, will become the division’s new CEO next month, Roche said Thursday. Simultaneously, Roche is elevating Levi Garraway, chief medical officer, to the executive committee.

February 4, 2023

J&J’s pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries

Life sciences

Fierce Pharma has obtained internal documents and video of a town hall meeting conducted this week describing what J&J called a “comprehensive review” of its portfolio. Moving forward, J&J plans to operate its vaccines and infectious diseases outfits as one group, the executives explained.

How can we help you?

We're easy to reach